Browse the evidence

Epigenetic mechanisms, including DNA methylation, histone modification, and non-coding RNA regulation, play a critical role in the initiation and progression of metabolic diseases such as type 2 diabetes, obesity, and NAFLD.

Your lifestyle choices (diet, exercise, stress) can influence how your genes are expressed through epigenetic mechanisms. This means metabolic health is not fixed by your DNA sequence alone. Understanding these mechanisms opens the door for precision medicine, including biomarkers for early detection and drugs that target epigenetic modifications.

Obstructive sleep apnea syndrome (OSAS) causes intermittent hypoxia (IH) and hypercapnia, which trigger gut microbiota dysbiosis, intestinal barrier impairment, and altered metabolites, leading to systemic oxidative stress, inflammation, and sympathetic activation.

If you have OSAS, treating the airway collapse is essential to stop the cycle of intermittent hypoxia that damages your gut and increases systemic inflammation. This goes beyond just feeling rested; it prevents long-term metabolic and cardiovascular harm.

Nocturnal rostral fluid shift, where fluid accumulated in the legs during the day redistributes to the neck upon lying down, increases tissue pressure and upper airway collapsibility, predisposing individuals to OSAS.

If you have leg swelling, try elevating your legs during the day or wearing compression stockings. This can reduce the amount of fluid that shifts to your neck at night, potentially easing airway collapse.

Obesity prevalence trends in high-income countries have stabilized or plateaued since approximately 2000, contrasting with continuous increases in low- and middle-income nations.

If you live in a high-income country, the trend of rising obesity rates has likely slowed or stopped for your demographic since 2000. This suggests that societal changes (diet, activity) have reached a new equilibrium. However, this stability is not guaranteed to persist, and severe obesity is still rising, so individual action remains critical.

Severe obesity is rising rapidly in high-income countries and is projected to double in prevalence between 2020 and 2035, posing a significant threat to healthcare systems.

Even if general obesity rates have stabilized in your country, severe obesity is doubling. This means the health risks and healthcare costs are increasing significantly. Focus on preventing the progression to severe obesity through early intervention.

Positive Airway Pressure (PAP) therapy is the primary medical treatment for Obstructive Sleep Apnea (OSA) and significantly reduces daytime sleepiness and apnea-hypopnea index (AHI), though its impact on cardiovascular mortality and hard endpoints remains less definitive.

If you have OSA, PAP therapy is the most effective way to keep your airway open and reduce sleepiness. You need to find the right pressure and mask type, which may take some trial and error, but sticking with it is crucial for your long-term health and quality of life.

Surgical interventions and oral appliances are alternative treatments for OSA, with efficacy varying by patient anatomy and severity, often serving as options when PAP is not tolerated.

If PAP doesn't work for you, talk to your doctor about surgical options or oral appliances. These can be effective for some people, especially if your anatomy is suitable, but they require careful evaluation.

Global efforts to reduce malnutrition have been more than offset by a rapidly rising obesity burden, resulting in a widening 'double burden' of disease where obesity-related disability-adjusted life years (DALYs) now vastly exceed malnutrition-related DALYs.

Global health strategies must stop treating hunger and obesity as separate issues. As countries develop and reduce starvation, they often swing into obesity epidemics. Effective policy requires a unified approach that ensures food security while simultaneously preventing the shift toward unhealthy, obesity-driving diets, particularly in low-to-middle income regions undergoing rapid economic change.

Mitochondrial dysfunction acts as a primary driver of skeletal muscle atrophy by triggering catabolic signaling pathways that promote the expression of muscle atrophy genes and increasing oxidative stress.

To support muscle mass, prioritize activities that improve mitochondrial health, such as regular aerobic and resistance exercise. These interventions help regulate mitochondrial function and may prevent or treat muscle atrophy, especially in aging or diseased states.

Dietary fiber interventions in healthy adults do not consistently produce significant increases in total or individual short-chain fatty acid (SCFA) levels, with outcomes strictly dependent on fiber type, dose, and analytical methodology.

Do not assume that taking a generic fiber supplement will automatically boost your short-chain fatty acids. The effect is highly variable and depends on the specific type of fiber (e.g., inulin vs. resistant starch), the dose, and your individual gut microbiome composition. Focus on diverse fiber sources from whole foods rather than expecting a uniform metabolic boost from supplements.

The analytical method used to measure SCFAs (e.g., GC vs. HPLC) significantly influences the detection of statistically significant changes, with GC-based methods on plasma/serum showing more frequent significant changes than HPLC on feces.

When evaluating fiber studies, check the measurement method. Studies using Gas Chromatography (GC) on blood samples are more likely to report significant SCFA changes than those using HPLC on feces, even if the biological effect is similar. This highlights the difficulty in measuring blood SCFAs due to low concentrations.

In heart failure with reduced ejection fraction (HFrEF), higher adiposity measured by waist-to-height ratio is associated with a significantly higher risk of heart failure hospitalization, and the 'obesity-survival paradox' (where higher BMI appeared protective) is eliminated when adjusting for natriuretic peptides and other prognostic variables.

For patients with heart failure and reduced ejection fraction, relying on BMI to assess risk is misleading. Higher waist-to-height ratio (indicating central adiposity) is linked to a significantly higher risk of hospitalization. The idea that being 'overweight' is protective in heart failure is a statistical artifact; once you account for fluid retention and biomarkers like natriuretic peptides, higher adiposity clearly increases risk. Focus on healthy body composition rather than just scale weight.

BMI is a suboptimal tool for predicting chronic disease risk and diagnosing obesity because it fails to distinguish between fat mass and muscle mass, leading to misclassification of athletes and elderly individuals.

Do not rely on BMI alone to determine your health status, especially if you are an athlete or elderly. BMI cannot distinguish between muscle and fat. Use waist circumference or body composition analysis for a more accurate assessment of obesity and health risk.

As food systems transition from rural/traditional to industrial/consolidated, the affordability of a recommended nutritious diet improves significantly, yet industrial systems fail to deliver optimal nutrition, environmental sustainability, and equity.

Do not assume that simply having the money to buy a 'healthy' diet guarantees good health outcomes. In industrialized food systems, while you can afford the recommended diet, the actual quality, environmental impact, and equity of that food supply may still be suboptimal. Focus on the quality and source of food, not just its cost.

Oxidative stress, driven by excessive reactive oxygen species (ROS) from both endogenous (mitochondrial dysfunction, NOX activity) and exogenous (air pollution, UV, smoking) triggers, is a central causal mechanism in cellular senescence and the pathogenesis of aging-related diseases including neurodegeneration, cardiovascular disease, and cancer.

Aging and many chronic diseases are linked to cellular damage from oxidative stress. You can mitigate this by reducing exposure to external triggers like air pollution, UV radiation, and smoking, and by maintaining healthy lifestyle habits such as regular exercise and a balanced diet rich in antioxidants, which help manage internal ROS levels.

Dietary fiber promotes the production of beneficial tryptophan metabolites, specifically indolelactic acid (ILA) and indolepropionic acid (IPA), by making more tryptophan available for Stickland fermentation.

To support gut health and potentially reduce the production of harmful metabolites like indole, incorporate fermentable fibers (such as pectin found in apples) into your diet. This encourages beneficial bacteria to produce protective metabolites (ILA, IPA) and suppresses the production of indole, which is linked to chronic kidney disease risk.

Aging is characterized by a loss of structural and functional complexity in physiological systems, which impairs adaptability and leads to disease.

View aging not just as damage accumulation, but as a loss of system flexibility. Maintaining diverse physical and cognitive challenges may help preserve the 'complexity' that protects against sudden health failures.

Wearable sleep-tracking technology introduces healthcare disparities because sensor performance is negatively impacted by person-specific factors such as skin color and obesity, leading to inaccurate data for minority and obese populations.

If you have darker skin or obesity, be aware that consumer sleep wearables may be less accurate for you. Do not use these devices for critical health decisions without verifying their accuracy against clinical standards for your specific body type.

For individuals consuming a balanced diet, calcium and vitamin D supplementation provides little to no beneficial or detrimental effect on fracture prevention.

If you eat a balanced diet and are not on osteoporosis medication, you likely do not need calcium or vitamin D supplements for fracture prevention. Focus on getting these nutrients from food. If you are on medication or have a deficiency, your doctor may recommend specific doses.

Cellular senescence drives inflammaging through the secretion of the Senescence-Associated Secretory Phenotype (SASP), which promotes chronic sterile inflammation and age-related pathologies.

Aging is associated with the accumulation of 'zombie' cells (senescent cells) that secrete inflammatory signals (SASP). This chronic inflammation contributes to many age-related diseases. While senolytics (drugs that kill these cells) are being developed, current evidence supports lifestyle factors like physical activity, which improves mitochondrial function and may help manage inflammation.

Mitochondrial dysfunction, specifically the release of mitochondrial DAMPs (mtDAMPs) like oxidized mtDNA and cardiolipin, activates innate immune pathways (NLRP3, cGAS/STING, NF-κB) to drive inflammaging.

Mitochondrial health is crucial for managing inflammation. Impaired mitochondria release signals that trigger chronic inflammation. Physical activity improves mitochondrial function and may help reduce this inflammatory burden.

Higher dietary resistant starch intake is NOT significantly associated with reduced cardiovascular disease (CVD) mortality.

Do not rely on resistant starch alone to protect your heart. This study found no significant link between RS intake and reduced cardiovascular mortality. While RS may offer other benefits, managing overall cardiovascular risk requires a holistic approach including blood pressure, lipid management, and overall diet quality, not just increasing RS.

There is no statistically significant association between weight loss (amount or frequency) and cancer mortality in men or women.

Losing weight, whether once or repeatedly, does not appear to reduce your risk of dying from cancer based on this study. Focus on other aspects of health.

Perivascular Fat Attenuation Index (FAI) measured via cardiac CT serves as a biomarker for coronary inflammation and predicts cardiac mortality, with values above -70.1 HU indicating a 6- to 9-fold higher adjusted risk of future cardiac mortality.

If you are getting a heart scan for chest pain, ask your doctor about the Fat Attenuation Index (FAI). This AI-enhanced measurement looks at the fat around your heart arteries to detect hidden inflammation. A high FAI score means your risk of a heart event is much higher, even if your arteries don't look blocked yet. This helps doctors treat you before a major problem occurs.